Simultaneous Integration of Multi-omics Data Improves the Identification of Cancer Driver Modules

An, 2016, Ncg 5.0: updates of a manually curated repository of cancer genes and associated properties from cancer mutational screenings, Nucleic Acids Res., 44, D992, 10.1093/nar/gkv1123 Babur, 2015, Systematic identification of cancer driving signaling pathways based on mutual exclusivity of genomic alterations, Genome Biol., 16, 45, 10.1186/s13059-015-0612-6 Cancer Genome Atlas Network, 2012, Comprehensive molecular portraits of human breast tumours, Nature, 490, 61, 10.1038/nature11412 Cancer Genome Atlas Research Network, 2008, Comprehensive genomic characterization defines human glioblastoma genes and core pathways, Nature, 455, 1061, 10.1038/nature07385 Cancer Genome Atlas Research Network, 2011, Integrated genomic analyses of ovarian carcinoma, Nature, 474, 609, 10.1038/nature10166 Cerami, 2012, The cbio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data, Cancer Discov., 2, 401, 10.1158/2159-8290.CD-12-0095 Chen, 2005, Arf-bp1/mule is a critical mediator of the arf tumor suppressor, Cell, 121, 1071, 10.1016/j.cell.2005.03.037 Cheng, 2014, Xpo1 (crm1) inhibition represses stat3 activation to drive a survivin-dependent oncogenic switch in triple-negative breast cancer, Mol. Cancer Ther., 13, 675, 10.1158/1535-7163.MCT-13-0416 Ciriello, 2012, Mutual exclusivity analysis identifies oncogenic network modules, Genome Res., 22, 398, 10.1101/gr.125567.111 Constantinescu, 2016, Timex: a waiting time model for mutually exclusive cancer alterations, Bioinformatics, 32, 968, 10.1093/bioinformatics/btv400 Cristea, 2017, Pathtimex: joint inference of mutually exclusive cancer pathways and their progression dynamics, J. Comput. Biol., 24, 603, 10.1089/cmb.2016.0171 Curtis, 2012, The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups, Nature, 486, 346, 10.1038/nature10983 Davoli, 2013, Cumulative haploinsufficiency and triplosensitivity drive aneuploidy patterns and shape the cancer genome, Cell, 155, 948, 10.1016/j.cell.2013.10.011 Forbes, 2010, COSMIC (the catalogue of somatic mutations in cancer): a resource to investigate acquired mutations in human cancer, Nucleic Acids Res., 38, D652, 10.1093/nar/gkp995 Fox, 1991, Recombinant nidogen consists of three globular domains and mediates binding of laminin to collagen type iv, EMBO J., 10, 3137, 10.1002/j.1460-2075.1991.tb04875.x Freedman, 1998, Nuclear export is required for degradation of endogenous p53 by mdm2 and human papillomavirus e6, Mol. Cell. Biol., 18, 7288, 10.1128/MCB.18.12.7288 Geiger, 2010, Super-SILAC mix for quantitative proteomics of human tumor tissue, Nat. Methods, 7, 383, 10.1038/nmeth.1446 Gjerdrum, 2010, Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival, Proc. Natl. Acad. Sci. USA, 107, 1124, 10.1073/pnas.0909333107 Glaab, 2012, EnrichNet: network-based gene set enrichment analysis, Bioinformatics, 28, i451, 10.1093/bioinformatics/bts389 Han, 2015, Trrust: a reference database of human transcriptional regulatory interactions, Sci. Rep., 5, 11432, 10.1038/srep11432 Hanahan, 2000, The hallmarks of cancer, Cell, 100, 57, 10.1016/S0092-8674(00)81683-9 Hofree, 2016, Challenges in identifying cancer genes by analysis of exome sequencing data, Nat. Commun., 7, 12096, 10.1038/ncomms12096 Hollestelle, 2010, Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines, Breast Cancer Res. Treat., 121, 53, 10.1007/s10549-009-0460-8 Huret, 2004, An atlas on genes and chromosomes in oncology and haematology, Cell. Mol. Biol., 50, 805 Jerby-Arnon, 2014, Predicting cancer-specific vulnerability via data-driven detection of synthetic lethality, Cell, 158, 1199, 10.1016/j.cell.2014.07.027 Karaayvaz, 2018, Unravelling subclonal heterogeneity and aggressive disease states in tnbc through single-cell rna-seq, Nat. Commun., 9, 3588, 10.1038/s41467-018-06052-0 Karr, 2012, A whole-cell computational model predicts phenotype from genotype, Cell, 150, 389, 10.1016/j.cell.2012.05.044 Kim, 2015, Memcover: integrated analysis of mutual exclusivity and functional network reveals dysregulated pathways across multiple cancer types, Bioinformatics, 31, i284, 10.1093/bioinformatics/btv247 Konecny, 2016, Parp inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directions, Br. J. Cancer, 115, 1157, 10.1038/bjc.2016.311 Lee, 2006, Identification of the basement membrane protein nidogen as a candidate ligand for tumor endothelial marker 7 in vitro and in vivo, FEBS Lett., 580, 2253, 10.1016/j.febslet.2006.03.033 Leiserson, 2013, Simultaneous identification of multiple driver pathways in cancer, PLoS Comput. Biol., 9, e1003054, 10.1371/journal.pcbi.1003054 Leiserson, 2015, Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes, Nat. Genet., 47, 106, 10.1038/ng.3168 McCauley, 2012, Preclinical evaluation of selective inhibitors of nuclear export (sine) in basal-like breast cancer (blbc), J. Clin. Oncol., 30, 1055, 10.1200/jco.2012.30.15_suppl.1055 Milanezi, 2008, Egfr/her2 in breast cancer: a biological approach for molecular diagnosis and therapy, Expert Rev. Mol. Diagn., 8, 417, 10.1586/14737159.8.4.417 Ogata, 1999, KEGG: kyoto encyclopedia of genes and genomes, Nucleic Acids Res., 27, 29, 10.1093/nar/27.1.29 Ogiwara, 2012, CBP and p300 histone acetyltransferases contribute to homologous recombination by transcriptionally activating the BRCA1 and RAD51 genes, PLoS One, 7, e52810, 10.1371/journal.pone.0052810 Pao, 2000, CBP/p300 interact with and function as transcriptional coactivators of BRCA1, Proc. Natl. Acad. Sci. USA, 97, 1020, 10.1073/pnas.97.3.1020 Parker, 2009, Supervised risk predictor of breast cancer based on intrinsic subtypes, J. Clin. Oncol., 27, 1160, 10.1200/JCO.2008.18.1370 Paull, 2013, Discovering causal pathways linking genomic events to transcriptional states using Tied Diffusion Through Interacting Events (TieDIE), Bioinformatics, 29, 2757, 10.1093/bioinformatics/btt471 Perou, 2000, Molecular portraits of human breast tumours, Nature, 406, 747, 10.1038/35021093 Pletscher-Frankild, 2015, DISEASES: text mining and data integration of disease-gene associations, Methods, 74, 83, 10.1016/j.ymeth.2014.11.020 Pozniak, 2016, System-wide clinical proteomics of breast cancer reveals global remodeling of tissue homeostasis, Cell Syst., 2, 172, 10.1016/j.cels.2016.02.001 Saal, 2005, PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma, Cancer Res., 65, 2554, 10.1158/0008-5472-CAN-04-3913 Schaefer, 2012, HIPPIE: integrating protein interaction networks with experiment based quality scores, PLoS One, 7, e31826, 10.1371/journal.pone.0031826 Scholler, 2007, Ca125 in ovarian cancer, Biomark. Med., 1, 513, 10.2217/17520363.1.4.513 Song, 2012, The functions and regulation of the PTEN tumour suppressor, Nat. Rev. Mol. Cell Biol., 13, 283, 10.1038/nrm3330 Sørlie, 2001, Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications, Proc. Natl. Acad. Sci. USA, 98, 10869, 10.1073/pnas.191367098 Subramanian, 2005, Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles, Proc. Natl. Acad. Sci. USA, 102, 15545, 10.1073/pnas.0506580102 Turner, 2006, Basal-like breast cancer and the BRCA1 phenotype, Oncogene, 25, 5846, 10.1038/sj.onc.1209876 Turner, 2007, BRCA1 dysfunction in sporadic basal-like breast cancer, Oncogene, 26, 2126, 10.1038/sj.onc.1210014 Tyanova, 2016, Proteomic maps of breast cancer subtypes, Nat. Commun., 7, 10259, 10.1038/ncomms10259 Ulitsky, 2010, Expander: from expression microarrays to networks and functions, Nat. Protoc., 5, 303, 10.1038/nprot.2009.230 2015, UniProt: a hub for protein information, Nucleic Acids Res., 43, D204, 10.1093/nar/gku989 Vandin, 2012, De novo discovery of mutated driver pathways in cancer, Genome Res., 22, 375, 10.1101/gr.120477.111 Vaughan, 2015, Huwe1 ubiquitylates and degrades the rac activator tiam1 promoting cell-cell adhesion disassembly, migration, and invasion, Cell Rep., 10, 88, 10.1016/j.celrep.2014.12.012 Vogelstein, 2013, Cancer genome landscapes, Science, 339, 1546, 10.1126/science.1235122 Wight, 2002, Versican: a versatile extracellular matrix proteoglycan in cell biology, Curr. Opin. Cell Biol., 14, 617, 10.1016/S0955-0674(02)00375-7 Wu, 2015, Comet: a statistical approach to identify combinations of mutually exclusive alterations in cancer, Cancer Res., 75, 1936, 10.1158/1538-7445.AM2015-1936 Zhang, 2008, Axl is a potential target for therapeutic intervention in breast cancer progression, Cancer Res., 68, 1905, 10.1158/0008-5472.CAN-07-2661